Picture of GlucoTrack logo

GCTK GlucoTrack Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for GlucoTrack, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.07-4.43-7.1-22.6-19.4
Depreciation
Non-Cash Items0.3090.4990.336103.9
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.0530.1840.190.0670.209
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-3.77-3.73-6.56-12.5-15.2
Capital Expenditures-0.005-0.0010-0.104-0.096
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0040.0020
Sale of Fixed Assets
Cash from Investing Activities-0.0010.0010-0.104-0.096
Financing Cash Flow Items3.54
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities08.7313.717
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.77-3.782.171.131.76